Estudios
I+D+I
Institución
Internacional
Vida Universitaria
Atlantis Institut des Sciences Fictives
Recherche
Soumettre
Personnaliser
Vos alertes
Vos paniers
Vos recherches
Aide
EN
/
ES
Accueil
>
articulos
> Dry Needling and Antithrombotic Drugs
Statistiques d'utilisation
Graphiques
Dry Needling and Antithrombotic Drugs
Muñoz, María
;
Dommerholt, Jan
;
Pérez-Palomares, Sara
(Universidad de Zaragoza)
;
Herrero, Pablo
(Universidad de Zaragoza)
;
Calvo, Sandra
(Universidad de Zaragoza)
Resumen:
Many clinicians increasingly use dry needling in clinical practice. However, whether patients'' intake of antithrombotic drugs should be considered as a contraindication for dry needling has not been investigated to date. As far as we know, there are no publications in analyzing the intake of antiplatelet or anticoagulant agents in the context of dry needling techniques. A thorough analysis of existing medications and how they may impact various needling approaches may contribute to improved evidence-informed clinical practice. The primary purpose of this paper is to review the current knowledge of antithrombotic therapy in the context of dry needling. In addition, reviewing guidelines of other needling approaches, such as electromyography, acupuncture, botulinum toxin infiltration, and neck ultrasound-guided fine-needle aspiration biopsy, may provide specific insights relevant for dry needling. Based on published data, taking antithrombotic medication should not be considered an absolute contraindication for dry needling techniques. As long as specific dry needling and individual risks are properly considered, it does not change the risk and safety profile of dry needling. Under specific circumstances, the use of ultrasound guidance is recommended when available. © 2022 María Muñoz et al.
Idioma:
Inglés
DOI:
10.1155/2022/1363477
Año:
2022
Publicado en:
Pain research and management
2022 (2022), 1363477 [10 pp.]
ISSN:
1203-6765
Factor impacto JCR:
2.9 (2022)
Categ. JCR:
CLINICAL NEUROLOGY
rank: 116 / 212 = 0.547
(2022)
- Q3
- T2
Factor impacto CITESCORE:
4.0 -
Neuroscience
(Q3) -
Medicine
(Q2)
Factor impacto SCIMAGO:
0.562 -
Anesthesiology and Pain Medicine
(Q2) -
Neurology
(Q3)
Tipo y forma:
Article (Published version)
Área (Departamento):
Área Fisioterapia
(
Dpto. Fisiatría y Enfermería
)
Exportado de SIDERAL (2024-03-18-13:16:39)
Permalink:
Copy
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
articulos
Retour à la recherche
Notice créée le 2022-06-06, modifiée le 2024-03-19
Versión publicada:
PDF
Évaluer ce document:
Rate this document:
1
2
3
4
5
(Pas encore évalué)
Ajouter au panier personnel
Exporter vers
BibTeX
,
MARC
,
MARCXML
,
DC
,
EndNote
,
NLM
,
RefWorks